Synapse - Find an Expert

68 Results

Mortality results from the Göteborg randomised population-based prostate-cancer screening trial

Journal Article

Hugosson, J.; Carlsson, S.; Aus, G.; Bergdahl, S.; Khatami, A.; Lodding, P.; Pihl, C. G.; Stranne, J.; Holmberg, E.; Lilja, H.
Lancet Oncology (2010)

Fulltext@MSK | Save

Oral poly(ADP-ribose) polymerase inhibitor olaparib in patients with BRCA1 or BRCA2 mutations and recurrent ovarian cancer: A proof-of-concept trial

Journal Article

Audeh, M. W.; Carmichael, J.; Penson, R. T.; Friedlander, M.; Powell, B.; Bell-Mcguinn, K. M.; Scott, C.; Weitzel, J. N.; Oaknin, A.; Loman, N.; more...
Lancet (2010)

Fulltext@MSK | Save

Association of reported prostate cancer risk alleles with PSA levels among men without a diagnosis of prostate cancer

Journal Article

Wiklund, F.; Zheng, S. L.; Sun, J.; Adami, H. O.; Lilja, H.; Hsu, F. C.; Stattin, P.; Adolfsson, J.; Cramer, S. D.; Duggan, D.; more...
Prostate (2009)

Fulltext@MSK | Save

Prostate-Specific Antigen Velocity for Early Detection of Prostate Cancer: Result from a Large, Representative, Population-based Cohort

Journal Article

Vickers, A. J.; Wolters, T.; Savage, C. J.; Cronin, A. M.; O'brien, M. F.; Pettersson, K.; Roobol, M. J.; Aus, G.; Scardino, P. T.; Hugosson, J.; more...
European Urology (2009)

Fulltext@MSK | Save

Test sensitivity in the European prostate cancer screening trial: Results from Finland, Sweden, and the Netherlands

Journal Article

Auvinen, A.; Raitanen, J.; Moss, S.; De Koning, H. J.; Hugosson, J.; Tammela, T.; Roobol, M.; Lilja, H.; Hakama, M.
Cancer Epidemiology Biomarkers and Prevention (2009)

Fulltext@MSK | Save

A panel of kallikrein markers can reduce unnecessary biopsy for prostate cancer: Data from the European Randomized Study of Prostate Cancer Screening in Göteborg, Sweden

Journal Article

Vickers, A. J.; Cronin, A. M.; Aus, G.; Pihl, C. G.; Becker, C.; Pettersson, K.; Scardino, P. T.; Hugosson, J.; Lilja, H.
BMC Medicine (2008)

Fulltext@MSK | Save

Long-term prediction of prostate cancer: Prostate-specific antigen (PSA) velocity is predictive but does not improve the predictive accuracy of a single PSA measurement 15 years or more before cancer diagnosis in a large, representative, unscreened population